Skip to content

Serum Metabolomic Profile-Based Precision Dietary Guidance for Adults with Obesity

Serum Metabolomic Profile-Based Precision Dietary Guidance for Adults with Obesity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123078
Enrollment
Unknown
Registered
2026-04-21
Start date
2025-10-15
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

Healthy control group:None

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Obese group 1.Aged 18-65 years (inclusive), regardless of gender or ethnicity. 2.Diagnosed with primary obesity and BMI =28 kg/m². 3.No use of weight-loss medications or metabolic surgery or other weight intervention measures within the past 3 months. 4.Provided voluntary written informed consent. Healthy control group 1. Aged 18-65 years (inclusive); no restrictions on gender or ethnicity; 2. Healthy individuals with a body mass index (BMI) between 18.5-23.9 kg/m²; excludes those with obvious acute or chronic diseases, recent medication use, or abnormal diet; 3. Assessed by the researcher as suitable to participate in this study; 4. Voluntarily willing to participate in the clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Obese group 1.Exclude subjects with secondary obesity. 2.Concurrent severe medical conditions or unstable chronic diseases. 3.Pregnant or lactating women, or those planning pregnancy. 4.Active malignancy, severe psychiatric disorders, or other conditions that may affect compliance. 5.Antibiotic use within 2 weeks prior to screening. 6.Participation in another interventional clinical trial within 4 weeks prior to screening; 7.Any other condition that, in the investigator's judgment, would make the subject unsuitable for participation in the study. Healthy control group 1. Combined with other severe organic diseases or the disease is in the acute attack phase; 2. Participated in other interventional clinical trials (including drugs, nutritional preparations, medical devices, etc.) within 4 weeks before screening; 3. Other conditions that the investigator believes are not suitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
weight;Waist Circumference;Body composition;Serum Metabolomic Characteristics;

Secondary

MeasureTime frame
Complete Blood Countand C-Reactive Protein;Blood Biochemistry;Gut microbiota;Glucose;Serum Insulin;Serum Lipid Profile and Serum Uric Acid;

Countries

China

Contacts

Public ContactHong Cao

Affiliated Hospital of Jiangnan University

violet_cao@163.com+86 510 8260 7391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026